Titan Biotech Ltd Share Price Today - Titan Biotech Ltd Stock Price Live NSE/BSE

Titan Biotech Ltd

NSE: BSE: 524717

₹1212.15

(6.53%)

Sat, 14 Feb 2026, 01:19 am

MTF 5xInvest in Titan Biotech Ltd with 5x Leverage Buy with MTF

Market Cap9.4B

PE Ratio36.82

Dividend0.18

Health Technology

Biotechnology

24.5K

Titan Biotech Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1001.68
Net Profit
18.27
P/B
2.27
Sector P/E
32.04
P/E
16.18
EV/EBITDA
11.78
Debt/Equity (Industry)
0.28
Interest Cover (Industry)
4.34
ROCE (Industry)
8.45
RONW (Industry)
6.56
ROE
12.74
ROCE
16.72
Debt/Equity
0.04
EPS (TTM)
32.92
Dividend Yield
0.16
Book Value
201.38
Interest Cover
31.46

Analysis

all

Pros

Titan Biotech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Titan Biotech is profitable, therefore cash runway is not a concern.
Titan Biotech is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (24.6%, greater than 20% of total debt).
Debt is covered by short term assets, assets are 1.7x debt.

Cons

Unable to calculate sustainability of dividends as Titan Biotech has not reported any payouts.
Unable to evaluate Titan Biotech's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Titan Biotech's dividend against the top 25% market benchmark as the company has not reported any payouts.
The level of debt compared to net worth has increased over the past 5 years (39.8% vs 58.8% today).
Titan Biotech's level of debt (58.8%) compared to net worth is high (greater than 40%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	55.78	55.78	55.88	55.88	55.88
FII	0	0	0	0	0
DII	0.03	0.03	0.03	0.01	0
Public	44.19	44.19	44.09	44.11	44.12
Government	0	0	0	0	0

Technical Analysis

RSI

72.15

MACD

25.82

50 DMA

1039.02

200 DMA

770.82

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	1435.90	1213.55	1072.40	991.20	850.05	768.85	546.50
Fibonacci	1213.55	1128.61	1076.14	991.20	906.26	853.79	768.85
Camarilla	992.40	972.01	951.63	991.20	910.87	890.49	870.10

Pivots Level: Classic

+444.70

1435.90

+222.35

1213.55

+81.20

1072.40

991.20

Pivot Point

LTP: 1212.15

-141.15

850.05

-222.35

768.85

-444.70

546.50

Moving Average

SMAEMA

Period

Value

10-EMA
1078.95
20-EMA
1049.22
30-EMA
1040.84
50-EMA
1030.08
100-EMA
973.45
200-EMA
861.13

Announcement Date	Purpose	Action	Ex Date
12 Feb 2026	board-meetings	Quarterly Results
29 Nov 2025	split	1:5 Splits of Equity Shares	20 Feb 2026
13 Aug 2025	agm
30 May 2025	dividend	₹2.00 Dividend /Share	19 Sept 2025
09 Sept 2024	agm
29 May 2024	dividend	₹2.00 Dividend /Share	24 Sept 2024
01 Sept 2023	agm
29 May 2023	dividend	₹1.80 Dividend /Share	22 Sept 2023
26 Aug 2022	agm
30 May 2022	dividend	₹1.50 Dividend /Share	23 Sept 2022

Titan Biotech Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Cipla Ltd

Divis Laboratories Ltd

Titan Biotech Ltd About

Titan Biotech is a leading manufacturer of cotton specialty yarns and cotton sewing threads catering to both local and export markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1992

Headquarters

CEO

Rohit Jain

Employees

Contact

Website

http://www.titanbiotechltd.com

hrd@titanbiotechltd.com

Phone

91-011-27355742/27674615

Location

A-902 A RIICO Industrial Area, Phase III Alwar District, Bhiwadi, Rajasthan, 301019

Year	History
1992	The Company was incorporated as a public limited company. The Company obtained the certificate of Commencement of Business.
2007	The Company received export orders worth more than USD 130,000.
2010	Titan Biotech Ltd recommended a dividend of 5% on equity shares.
2014	Titan Biotech Ltd recommended a dividend of Rs. 0.75 per equity share.

Client Name	Order Side	QTY	Avg Price	Date
No Result Found

Titan Biotech Ltd News

Titan Biotech Gets New ISIN for Share Sub-Division

Titan Biotech Limited receives new ISIN INE150C01029 for equity share sub-division from Rs. 10 to Rs. 2 face value, effective February 20, 2026, with activation confirmed by NSDL and CDSL.

12 Feb 2026

co actions results

Titan Biotech Q3FY26 Results: Strong Growth Continues

Titan Biotech reports robust Q3FY26 performance with revenue rising 47.64% YoY to ₹5,650.57 lakhs and net profit surging 107.01% to ₹786.82 lakhs, maintaining strong momentum.

12 Feb 2026

co actions results

Titan Biotech Opens Special Window for Share Transfer

Titan Biotech Limited announces special window for transfer and dematerialization of physical shares from February 5, 2026 to February 4, 2027, following SEBI circular guidelines.

06 Feb 2026

co actions results

Titan Biotech Board Meet on Feb 12 for Q3FY26 Results

Titan Biotech Limited has scheduled a board meeting on February 12, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window remains closed until 48 hours post-declaration.

03 Feb 2026

co actions results

Titan Biotech Reconstitutes Board Committees

Titan Biotech Limited reconstituted four key board committees effective January 2, 2026, appointing Mr. Brijesh Kumar Singh and Mr. Debendra Kumar Sabat as members across all committees including Audit, Nomination & Remuneration, CSR, and Stakeholders Relationship.

03 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800